1044 related articles for article (PubMed ID: 10862190)
1. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.
Tung-Ping Poon R; Fan ST; Wong J
Ann Surg; 2000 Jul; 232(1):10-24. PubMed ID: 10862190
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
4. Influencing elements and treatment strategies associated with the relapse of hepatocellular carcinoma after surgery.
Li F; Guo Z; Wang H
Hepatogastroenterology; 2013; 60(125):1148-55. PubMed ID: 24298612
[TBL] [Abstract][Full Text] [Related]
5. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy.
Poon RT; Fan ST; O'Suilleabhain CB; Wong J
J Am Coll Surg; 2002 Sep; 195(3):311-8. PubMed ID: 12229937
[TBL] [Abstract][Full Text] [Related]
6. Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma.
Izumi R; Shimizu K; Iyobe T; Ii T; Yagi M; Matsui O; Nonomura A; Miyazaki I
Hepatology; 1994 Aug; 20(2):295-301. PubMed ID: 8045490
[TBL] [Abstract][Full Text] [Related]
7. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.
Xi T; Lai EC; Min AR; Shi LH; Wu D; Xue F; Wang K; Yan Z; Xia Y; Shen F; Lau WY; Wu MC
Hepatogastroenterology; 2012 Jun; 59(116):1198-203. PubMed ID: 22580673
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for hepatocellular carcinoma after curative treatment.
Jeng WJ; Lin CC; Chen WT; Sheen IS; Lin CY; Lin SM
Dig Dis; 2014; 32(6):747-54. PubMed ID: 25376293
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of clinical and pathological features in hepatocellular carcinoma.
Qin LX; Tang ZY
World J Gastroenterol; 2002 Apr; 8(2):193-9. PubMed ID: 11925590
[TBL] [Abstract][Full Text] [Related]
11. Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy.
Lu SD; Li L; Liang XM; Chen W; Chen FL; Fan LL; Ahir BK; Zhang WG; Zhong JH
Expert Rev Gastroenterol Hepatol; 2019 Nov; 13(11):1077-1088. PubMed ID: 31648568
[No Abstract] [Full Text] [Related]
12. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
13. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters.
Roayaie S; Frischer JS; Emre SH; Fishbein TM; Sheiner PA; Sung M; Miller CM; Schwartz ME
Ann Surg; 2002 Apr; 235(4):533-9. PubMed ID: 11923610
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors.
Poon RT; Fan ST; Lo CM; Liu CL; Wong J
Ann Surg; 1999 Feb; 229(2):216-22. PubMed ID: 10024103
[TBL] [Abstract][Full Text] [Related]
15. The current role of neoadjuvant/adjuvant/chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: a systematic review.
Lau WY; Lai EC; Lau SH
Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):124-33. PubMed ID: 19357024
[TBL] [Abstract][Full Text] [Related]
16. Treatment of hepatocellular carcinoma.
Tang ZY
Digestion; 1998 Aug; 59(5):556-62. PubMed ID: 9705539
[TBL] [Abstract][Full Text] [Related]
17. Multi-disciplinary Concurrent Management of Recurrent Hepatocellular Therapy is Superior to Sequential Therapy.
Fields TD; Philips P; Scoggins CR; Tatum C; Kelly L; McMasters KM; Martin RCG
World J Surg; 2017 May; 41(5):1331-1339. PubMed ID: 27905019
[TBL] [Abstract][Full Text] [Related]
18. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
[TBL] [Abstract][Full Text] [Related]
19. Three decades' experience in surgery of hepatocellular carcinoma.
Tang ZY; Yu YQ; Zhou XD; Yang BH; Lin ZY; Lu JZ; Ma ZC; Ye SL; Liu KD
Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():126-33. PubMed ID: 9210895
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma.
Zhang W; Zhang B; Chen XP
Front Med; 2021 Apr; 15(2):155-169. PubMed ID: 33754281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
